The campaign, which consisted of television, radio, newspaper, and collateral materials, was developed in order to recruit study participants for clinical research. The campaign was employed in recruiting participants not only for studies at the Lincoln facility but also for studies conducted by MDS Harris around the world. The campaign's content highlighted how study participants assisting in clinical research help improve the quality of life for people around the world.

"We wanted people to understand that by becoming a study participant they could help advance new medications and new delivery methods that would help people with arthritis, asthma, diabetes, or a host of other conditions," said Scott Logan, manager of global participant recruitment, MDS Harris.

For clinical research organizations, recruiting is the number one challenge. A solid recruitment program, like the one at MDS Harris, means studies will begin full and on time. The recruitment program at MDS Harris includes a state-of-the-art call center, full-time staff, physician referral networks, and community outreach programs - not to mention aggressive advertising programs such as the award-winning "Together, we're making lives better."

"When we introduced the theme in our recruiting campaign last fall, we felt it would help us communicate positive information about MDS Harris, and at the same time, allow us to acknowledge how important study participants are to our mission," said Cinda Orr, vice president, marketing, MDS Harris. "The campaign has been very successful in enrolling new study participants. It has also helped educate the public and the community about our role in the drug development."

MDS Harris has developed an active database of more than 100,000 study participants, consisting of both normal healthy and special populations. The company's locations throughout the world provide access to extensive recruitment opportunities.

MDS Harris, founded in 1933, is headquartered in Lincoln, Neb., and has grown to become a leading international clinical research organization serving the needs of the pharmaceutical and biotechnology industries. MDS Harris provides Phase I, II, III, and IV clinical research, SMO, bioanalytical, pharmacokinetic, statistical, and data management services from sites throughout North America, Europe, Africa, and Asia.

MDS Inc. (MHG.A, MHG.B) is a Canadian-based, international health and life sciences company. Its core purpose is to make a distinctive contribution to the health and well-being of people. MDS employs more than 7,000 highly skilled people at its global operations in Canada and the U.S., as well as in Northern Ireland, England, Belgium, Switzerland, Germany, South Africa, Japan, Taiwan, and China. The core businesses of MDS include: the production and distribution of diagnostic and therapeutic radioisotopes; the provision of laboratory information and management, and patented laboratory automation and software; drug discovery and development services for the world's biotechnology and pharmaceutical industries; manufacturing of ultra-trace detection equipment; and medical and hospital supplies and inventory management systems. Detailed information about the company is available on the MDS Web site at http://www.mdsintl.com or by calling 1-888-MDS-7222.

For further information, please contact Angie Thorell, MDS Harris, 621 Rose Street, Lincoln, Neb., Tel: (402) 476-2811, and visit our Web site at www.mdsharris.com.